Chemed CHE Lease Liability Payments - 2020 (Remaining Three Months)

Other financials

Revenue$657.5M+1.6%

Gross profit$215.8M-0.3%

Operating income$84.6M-10.7%

Net income$66.3M-7.6%

EPS (diluted)$4.84-0.4%

Cash & equivalents$16.9M-90.3%

Total debt$236.9M+63.3%

Total equity$848.0M-28.2%

Total assets$1.5B-11.0%

Operating cash flow$88.2M+169%

CapEx$17.1M+28.9%

Free cash flow$71.1M+265%

Market cap$5.79B-42.3%

Enterprise value$6.01B-39.6%

P/E22.3×-10.2×

P/S2.3×-1.8×

Gross margin32.4%-2.4pp

Operating margin12.9%-2.7pp

Net margin10.2%-2.2pp

FCF margin14.8%+2.2pp

Return on equity25.6%-0.5pp

Debt / equity0.3×+0.2×

Current ratio0.9×-0.9×

Reported directly by Chemed in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear.

The official record: Chemed’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and see it in context, right in your chat.

What is Chemed's lease liability payments - 2020 (remaining three months)?: Chemed (CHE) reported lease liability payments - 2020 (remaining three months) of $38.5M in Q1 2026.
How has Chemed's lease liability payments - 2020 (remaining three months) changed year-over-year?: Chemed's lease liability payments - 2020 (remaining three months) increased by 0.9% year-over-year, from $38.15M to $38.5M.